"My medicine is making me stronger," 7-year-old Hudson Sanford says after receiving a breakthrough gene therapy for Duchenne ...

Discover six innovative clinical-stage biotech companies fostering R&D in the Duchenne muscular dystrophy therapeutic space.

A dispute over a Duchenne gene therapy highlights thorny issues surrounding FDA approvals and insurance policies.

Biotech reported positive interim data from a mid-stage trial of a treatment for the rare muscle disorder Duchenne muscular ...

Like many other parents, Theresa and I had never heard of DMD before Michael was diagnosed. It changed everything for us.

Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for ...

Givinostat, is an HDAC inhibitor (HDACi, a principle candidate, currently being developed for the treatment of DMD and BMD.

Avidity Biosciences, Inc. surges on positive developments in AOCs for muscular disorders, strategic partnerships, and ...

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today that the Company will ...

The play is known as the Jackson Special. Kelly Maynard, Jackson’s mom, said he was diagnosed with Duchenne’s Muscular Dystrophy when he was five years old, which has confined him to a wheelchair. The ...

Jar of Hope was all set to stage a half-marathon fundraiser along Route 9 in Western Monmouth County this weekend. Then the ...

A ‘Relive the 80s’ theme marked the occasion, which brought together 740 members of the commercial property industry at the ...